POINT Biopharma Global Inc.

POINT Biopharma Global Inc.

World Rank (Aug-2026)
8923
World Rank (Jan-05-2024)
8,923
World Rank (Jul-30-2023)
8,923
Market Cap (Jul-30-2023)
0.962 Billion USD
World Rank (Jan-07-2022)
13,170
Market Cap (Jan-07-2022)
0.515 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PNT
Headquarters City/State
Indiana
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
227 Million USD
Annual Operating Income in USD
126 Million USD
Annual Net Income in USD
98 Million USD
Annual Results for Period Ending
For year ending December-2022
Total Assets in USD
578 Million USD
Total Liabilities in USD
91 Million USD
Total Equity in USD
487 Million USD
Balance Sheet for Period Ending
As of December-2022
Business Sector
Healthcare
Biotechnology
Pharmaceutical
Company Website
POINT BIOPHARMA GLOBAL INC.
Company Profile
POINT Biopharma Global Inc. is a Clinical Stage Global Pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. The headquarters is in USA.
IPO Year
2020
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share